• Ryan Specialty targets modest margin expansion in most years through its Empower efficiency program while continuing growth investments.
• Revenue reached $3.25 billion for the 12 months ended September 30, 2026; adjusted EBITDAC totaled $1.03 billion.
• Organic revenue growth was 7.3% for the first nine months of 2026, versus 10.1% for full-year 2025.
• Growth investments remain the first priority for discretionary capital, with residual cash returned to shareholders.
• Share repurchase authorization totaled $600 million, with $150 million remaining as of September 30, 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ryan Specialty Holdings Inc. published the original content used to generate this news brief on October 29, 2026, and is solely responsible for the information contained therein.